Risky Business: Diagnosing and Treating Invasive Fungal Infections

Details

Risky Business: Diagnosing and Treating Invasive Fungal Infections consists of 3 brief lectures on the diagnosis and treatment of invasive fungal infection:

After completing Risky Business: Diagnosing and Treating Invasive Fungal Infections, you should be better able to:
• Describe the epidemiology and burden of invasive fungal infections in patients who are immunocompromised and/or Immunosuppressed.
• Incorporate the latest diagnostic techniques for invasive fungal infections to ensure that the appropriate therapy can be initiated in a timely manner.
• Integrate the latest evidence-based treatment guidelines and clinical data pertaining to the efficacy, safety, and prophylactic use of antifungal agents to optimize the management of invasive fungal infections.

Target Audience:
Hematologist-oncologists, medical oncologists, transplant surgeons, critical care surgeons, critical care pulmonologists, and other health care professionals involved in the treatment of patients with or at risk for invasive fungal infections.